Here’s our handpicked selection of the best blog posts, popular articles, and breaking biotech news of the last two weeks: Longevity enthusiasts...
What’s new in media and industry: Laura Deming’s intro to longevity, and more
Just getting started around here, or want to introduce someone new to the world of longevity science? This handy primer from Laura Deming (of Longevit...
Video interview with James Peyer: Longevity science from bench to clinic, and everything in between
No one should have to read during the holidays. That’s why we made you a video! I spoke to our own James Peyer about how he got started in the l...
Better together? Testing the first combination therapies for longevity
The normal mode of drug discovery is a pretty singular affair: one compound, one disease. This is enough for many traditional diseases, but when you’r...
In the media: Autophagy, APOE4 and amyloid alternatives
Had your curiosity piqued by our recent autophagy articles? Learn even more about this essential cellular process over at LEAF science! Human trials o...
In the media this week: Aubrey, AI, and advocacy
Trust your doctor to diagnose you correctly? The Washington Post reports that 2/3 of doctors treating dementia patients backpedal on treatment plans a...
Intriguing results for Thioflavin T, but reproducibility is the real winner in CITP
Bolstering results from a 2011 study, a team led by Buck Institute researcher Gordon Lithgow found the compound Thioflavin T to increase the lifespan ...
Challenges of developing medicines for aging
Startups developing medicines to slow or prevent the diseases of aging all follow a similar three-step strategy. First they start from data generated ...